Andy Whitlock

Andy Whitlock, PhD, is Vice President of Preclinical Research & Development at Ora. Dr. Whitlock oversees all aspects of preclinical development for both internally-funded and client-sponsored ophthalmic development projects from early PK and proof-of-concept studies through IND-enabling studies. Dr. Whitlock combines his robust therapeutic knowledge with his experience in executing preclinical research studies to deliver great value to clients in early stages of development. In addition to overseeing Ora’s internal laboratories, Dr. Whitlock has developed long-standing relationships with leading basic scientists and lab facilities to provide Ora and its clients with unique access to some of the most advanced and appropriate animal models.

Back to Leadership